Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat

Neuroscience

Volumn 136, Issue 2, 2005, Pages 531-538

  Miller, A D ^a   Forster, G L ^b   Yeomans, J S ^c   Blaha, C D ^d  

^a MACQUARIE UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d University of Memphis   (United States)

Author keywords

Acetylcholine; Chronoamperometry; Mesopontine; Scopolamine; Substantia nigra; Ventral tegmental area

Indexed keywords

DOPAMINE; MORPHINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE; URETHAN;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTRODE; FOREBRAIN; HYPOTHESIS; MALE; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; ELECTROCHEMISTRY; ELECTRODES; INJECTIONS, INTRAVENOUS; MALE; MESENCEPHALON; MORPHINE; MUSCARINIC ANTAGONISTS; NARCOTICS; NEOSTRIATUM; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SCOPOLAMINE; STEREOTAXIC TECHNIQUES; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTAL AREA;

EID: 27744542546     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.08.035     Document Type: Article

References (71)

1. R. Bals-Kubik, A. Ableitner, A. Herz, T.S. Shippenberg Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats J Pharmacol Exp Ther 264 1993 489 495
2. M.T. Bardo Neuropharmacological mechanisms of drug reward beyond dopamine in the nucleus accumbens Crit Rev Neurobiol 12 1998 37 67
3. A.S. Basile, I. Fedorova, A. Zapata, X. Liu, T. Shippenberg, A. Duttaroy, M. Yamada, J. Wess Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia Proc Natl Acad Sci U S A 99 2002 11452 11457
4. A. Bechara, D. van der Kooy A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived but not in deprived rats Behav Neurosci 106 1992 351 363
5. C.D. Blaha Evaluation of stearate-graphite paste electrodes for chronic measurement of extracellular dopamine concentrations in the mammalian brain Pharmacol Biochem Behav 55 1996 351 364
6. C.D. Blaha, M.E. Jung Electrochemical evaluation of stearate-modified graphite paste electrodes selective detection of dopamine is maintained after exposure to brain tissue J Electroanal Chem 310 1991 317 334
7. C.D. Blaha, D. Lui, A.G. Phillips Improved electrochemical properties of stearate-graphite paste electrodes after albumin and phospholipid treatments Biosens Bioelectron 11 1996 63 79
8. C.D. Blaha, A.G. Phillips A critical assessment of electrochemical procedures applied to the measurement of dopamine and its metabolites during drug-induced and species-typical behaviors Behav Pharmacol 7 1996 675 708
9. C.D. Blaha, P. Winn Modulation of dopamine efflux in the striatum following cholinergic stimulation of the substantia nigra in intact and pedunculopontine tegmental nucleus-lesioned rats J Neurosci 13 1993 1035 1044
10. C. Bolden, B. Cusack, E. Richelson Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells J Pharmacol Exp Ther 260 1992 576 580
11. M.A. Bozarth Neural basis of psychomotor stimulant and opiate reward evidence suggesting the involvement of a common dopaminergic system Behav Brain Res 22 1986 107 116
12. M.A. Bozarth Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats Brain Res 414 1987 77 84
13. M.A. Bozarth, R.A. Wise Intracranial self-administration of morphine into the ventral tegmental area in rats Life Sci 28 1981 551 555
14. M.P. Caulfield, N.J.M. Birdsall International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors Pharmacol Rev 50 1998 279 290
15. P. Celada, C.A. Paladini, J.M. Tepper GABAergic control of rat substantia nigra dopaminergic neurons role of globus pallidus and substantia nigra pars reticulata Neuroscience 89 1999 813 825
16. A. Chintoh, J. Fulton, N. Koziel, M. Aziz, M. Sud, J.S. Yeomans Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M Pharmacol Biochem Behav 76 2003 53 61
17. D.P. Devine, R.A. Wise Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats J Neurosci 14 1994 1978 1984
18. G. Di Chiara, V. Bassareo, S. Fenu, M.A. De Luca, L. Spina, C. Cadoni, E. Acquas, E. Carboni, V. Valentini, D. Lecca Dopamine and drug addiction the nucleus accumbens shell connection Neuropharmacology 47 2004 227 241
19. G. Di Chiara, A. Imperato Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci U S A 85 1988 5274 5278
20. F. Dorje, J. Wess, G. Lambrecht, R. Tacke, E. Mutschler, M.R. Brann Antagonist binding profiles of five cloned human muscarinic receptor subtypes J Pharmacol Exp Ther 256 1991 727 733
21. R.M. Eglen, S.R. Nahorski The muscarinic M5 receptor a silent or emerging subtype? Br J Pharmacol 130 2000 13 21
22. R.M. Eglen, N. Watson Selective muscarinic receptor agonists and antagonists Pharmacol Toxicol 78 1996 59 68
23. A. Fink-Jensen, I. Fedorova, G. Wortwein, D.P. Woldbye, T. Rasmussen, M. Thomsen, T.G. Bolwig, K.M. Knitowski, D.L. McKinzie, M. Yamada, J. Wess, A. Basile Role for M5 muscarinic acetylcholine receptors in cocaine addiction J Neurosci Res 74 2003 91 96
24. G.L. Forster, C.D. Blaha Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area Eur J Neurosci 12 2000 3596 3604
25. G.L. Forster, C.D. Blaha Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat Eur J Neurosci 17 2003 751 762
26. G.L. Forster, A.J. Falcon, A.D. Miller, G.A. Heruc, C.D. Blaha Effects of laterodorsal tegmentum excitotoxic lesions on behavioral and dopamine responses evoked by morphine and d-amphetamine Neuroscience 114 2002 817 823
27. G.L. Forster, J.S. Yeomans, J. Takeuchi, C.D. Blaha M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice J Neurosci 21 RC190 2001 1 6
28. M. Giorgetti, G. Hotsenpiller, W. Froestl, M.E. Wolf In vivo modulation of ventral tegmental area dopamine and glutamate efflux by local GABA (B) receptors is altered after repeated amphetamine treatment Neuroscience 109 2002 585 595
29. A.A. Grace, B.S. Bunney Paradoxical GABA excitation of nigral dopaminergic cells indirect mediation through reticulata inhibitory neurons Eur J Pharmacol 59 1979 211 218
30. A.A. Grace, B.S. Bunney Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity Brain Res 333 1985 271 284
31. P. Grillner, N. Berretta, G. Bernadi, T.H. Svensson, N.B. Mercuri Muscarinic receptors depress GABAergic synaptic transmission in rat midbrain dopamine neurons Neuroscience 96 2000 299 307
32. K. Gysling, R.Y. Wang Morphine-induced activation of A10 dopamine neurons in the rat Brain Res 277 1983 119 127
33. D.W. Hommer, A. Pert The actions of opiates in the rat substantia nigra an electrophysiological analysis Peptides 4 1983 603 608
34. E.T. Iwamoto, E.L. Way Circling behavior and stereotypy induced by intranigral opiate microinjections J Pharmacol Exp Ther 203 1977 347 359
35. S.W. Johnson, R.A. North Opioids excite dopamine neurons by hyperpolarization of local interneurons J Neurosci 12 1992 483 488
36. M.A. Klitenick, P. DeWitte, P.W. Kalivas Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA an in vivo microdialysis study J Neurosci 12 1992 2623 2632
37. G.F. Koob Drugs of abuse anatomy, pharmacology and function of reward pathways Trends Pharmacol Sci 13 1992 177 184
38. G.F. Koob, P.P. Sanna, F.E. Bloom Neuroscience of addiction Neuron 21 1998 467 476
39. P. Leone, D. Pocock, R.A. Wise Morphine-dopamine interaction ventral tegmental morphine increases nucleus accumbens dopamine release Pharmacol Biochem Behav 39 1991 469 472
40. L. Lu, N.J. Xu, X. Ge, W. Yue, W.J. Su, G. Pei, L. Ma Reactivation of morphine conditioned place preference by drug priming role of environmental cues and sensitization Psychopharmacology 159 2002 125 132
41. R.T. Matthews, D.C. German Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine Neuroscience 11 1984 617 625
42. M. Melis, G.L. Gessa, M. Diana Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain Prog Neuropsychopharmacol Biol Psychiat 24 2000 993 1006
43. F.J. Michel, J.M. Robillard, T. Louis-Eric Regulation of rat mesencephalic GABAergic neurones through muscarinic receptors J Physiol (Lond) 556 2004 429 445
44. A.D. Miller, C.D. Blaha Nigrostriatal dopamine release modulated by mesopontine muscarinic receptors Neuroreport 15 2004 1805 1808
45. A.D. Miller, C.D. Blaha Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat Eur J Neurosci 21 2005 1837 1846
46. A.D. Miller, G.L. Forster, K.M. Metcalf, C.D. Blaha Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors Neuroscience 111 2002 351 362
47. M. Morelli, S. Fenu, G. Di Chiara Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of μ and δ opioid receptors Brain Res 487 1989 120 130
48. J.M. Nazzaro, T.F. Seeger, E.L. Gardner Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds Pharmacol Biochem Behav 14 1981 325 331
49. S.A. Oakman, P.L. Faris, P.E. Kerr, C. Cozzari, B.K. Hartman Distribution of pontomesencephalic cholinergic neurons projecting to the substantia nigra differs significantly from those projecting to the ventral tegmental area J Neurosci 15 1995 5859 5869
50. M.C. Olmstead, K.B.J. Franklin Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test Neuroscience 57 1993 411 418
51. M.C. Olmstead, E.M. Munn, K.B.J. Franklin, R.A. Wise Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement J Neurosci 18 1998 5035 5044
52. C.A. Paladini, P. Celada, J.M. Tepper Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA (A) receptors in vivo Neuroscience 89 1999 799 812
53. G. Paxinos, C. Watson The rat brain in stereotaxic coordinates 3rd ed. 1997 Academic Press New York
54. 1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission Pharmacol Biochem Behav 63 1999 245 252
55. C.M. Reever, G. Ferrari-DiLeo, D.D. Flynn The M5 (m5) receptor subtype fact or fiction? Life Sci 60 1997 1105 1112
56. I. Sziraki, H. Sershen, A. Hashim, A. Lajtha Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens Neurochem Res 27 2002 253 261
57. M.E. Trulson, K. Arasteh Morphine increases the activity of midbrain dopamine neurons in vitro Eur J Pharmacol 114 1985 105 109
58. P.A. Van Dongen, C.L. Broekkamp, A.R. Cools Locus coeruleus and substantia nigra involvement in morphine-induced behavior Brain Res Bull 4 1979 307 311
59. M.T. Vilaro, J.M. Palacios, G. Mengod Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry Neurosci Lett 114 1990 154 159
60. H. Wang, K. Ng, D. Hayes, X. Gao, G. Forster, C. Blaha, J. Yeomans Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region Neuropsychopharmacology 29 2004 2126 2139
61. D.M. Weiner, A.I. Levey, M.R. Brann Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia Proc Natl Acad Sci U S A 87 1990 7050 7054
62. P. Winn Cholinergic stimulation of substantia nigra effects on feeding, drinking and sexual behaviour in the male rat Psychopharmacology 104 1991 208 214
63. R.A. Wise Opiate reward sites and substrates Neurosci Biobehav Rev 13 1989 129 133
64. R.A. Wise Neurobiology of addiction Curr Opin Neurobiol 6 1996 243 251
65. N.J. Woolf Cholinergic systems in mammalian brain and spinal cord Prog Neurobiol 37 1991 475 524
66. Z.X. Xi, E.A. Stein Increased mesolimbic GABA concentration blocks heroin self-administration in the rat J Pharmacol Exp Ther 294 2000 613 619
67. G. Yang, K. Xu, Q. Luo Clinical study of scopolamine detoxification for the treatment of heroin addicts Zhonghua Yi Xue Za Zhi 76 1996 141 144
68. G. Yang, W. Zhou, K. Xu The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts Zhonghua Yi Xue Za Zhi 79 1999 679 682
69. J. Yeomans, G. Forster, C. Blaha M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation Life Sci 68 2001 2449 2456
70. J.S. Yeomans, O. Kofman, V. McFarlane Cholinergic involvement in lateral hypothalamic rewarding brain stimulation Brain Res 329 1985 19 26
71. J.S. Yeomans, J. Takeuchi, M. Baptista, D.D. Flynn, K. Lepik, J. Nobrega, J. Fulton, M.R. Ralph Brain stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells J Neurosci 20 2000 8861 8867